divendres, 4 d’abril de 2014

Spain's largest pharmaceutical company, Grifols, backs Catalan independence for Catalonia

The Spain's largest pharmaceutical company, Grifols, became one of the first executives of a major corporation to back a Catalan leader seeking a referendum on independence for Catalonia.

The head of Barcelona-based Grifols, Victor Grifols, held up his company's history - growing from a small, family-owned business into the world's third-largest maker of blood plasma products - as an example for Artur Mas.

Grifols was founded in 1940 Josep Grifols Roig, a hematologist  and scientist. He was the first researcher to publish the plasmapheresis procedure in 1951. The company introduced its liquid IVIG product into the European market in the mid-1990s. In 2003 the company acquired certain assets of the LA -based Alpha Therapeutic as the basis of its American expansion.

On 2011, a year after announcing the $4 billion deal, Grifols completed a takeover of Talecris Biotherapeutics, headquartered in North Carolina. Grifols acquired the blood transfusion diagnostics unit from Novartis in 2013 as a "platform for global expansion".

During a speech at the inauguration of a plant outside Barcelona, on Tuesday, Chairman Victor Grifols turned to Catalonia's president Artur Mas, who was attending the opening.

"A company that is determined must not question that determination," Grifols said. "I know you're having a rough time, but if you are determined, keep pushing forward and don't back down."

Besides Grifols, Barcelona is home to some of Spain's biggest companies, including its third-biggest bank, Caixabank and smaller peer Sabadell, the global infrastructure company Abertis and the utility Gas Natural.

About Grifols
Reuters article

0 comentaris:

Publica un comentari a l'entrada